UBD and stage II colon cancer's chemotherapy

E-ISSN： 1440-1746|30|4|680-688

ISSN： 0815-9319

Source： JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol.30, Iss.4, 2015-04, pp. : 680-688

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Administration of adjuvant chemotherapy for stage II‐III colon cancer patients: An European population‐based study

INTERNATIONAL JOURNAL OF CANCER, Vol. 142, Iss. 7, 2018-04 ,pp. : 1480-1489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Economic Impact of Alternative Adjuvant Chemotherapy Regimens for Stage III Colon Cancer

Oncology Research and Treatment, Vol. 32, Iss. 11, 2009-10 ,pp. : 647-652

Karger

Access to resources Recommend Favorite

Adjuvant Chemotherapy in Stage III Colon Cancer with 5-Fluorouracil and Levamisole versus 5-Fluorouracil and Leucovorin

Oncology Research and Treatment, Vol. 25, Iss. 5, 2002-11 ,pp. : 426-430

Karger

Access to resources Recommend Favorite

Adjuvant Therapy with Edrecolomab versus Observation in Stage II Colon Cancer: A Multicenter Randomized Phase III Study*

Oncology Research and Treatment, Vol. 28, Iss. 6-7, 2005-06 ,pp. : 347-350

Karger

Access to resources Recommend Favorite

Adherence to treatment guidelines and survival for older patients with stage II or III colon cancer in Texas from 2001 through 2011

CANCER, Vol. 124, Iss. 4, 2018-02 ,pp. : 679-687

John Wiley & Sons Inc

Access to resources Recommend Favorite